Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Penicillin dosing for pneumococcal pneumonia

C S Bryan1, R Talwani, M S Stinson

  • 1Department of Medicine, University of South Carolina School of Medicine and Richland Memorial Hospital, Columbia 29203, USA.

Chest
|December 24, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cavitary lung lesions and quality of life after TB.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2024
Same author

Doravirine: a new non-nucleoside reverse transcriptase inhibitor for the treatment of HIV infection.

Drugs of today (Barcelona, Spain : 1998)·2020
Same author

Hepatitis C virus upregulates B-cell receptor signaling: a novel mechanism for HCV-associated B-cell lymphoproliferative disorders.

Oncogene·2015
Same author

Sofosbuvir for the treatment of chronic hepatitis C virus infection.

Drugs of today (Barcelona, Spain : 1998)·2014
Same author

Simeprevir: a macrocyclic HCV protease inhibitor.

Drugs of today (Barcelona, Spain : 1998)·2014
Same author

Dolutegravir, an HIV integrase inhibitor for the treatment of HIV infection.

Drugs of today (Barcelona, Spain : 1998)·2014
Same journal

The effect of a two-day stay at high altitude (2500 m) on right ventricular afterload and oxygen delivery in patients with pulmonary vascular disease A randomized controlled crossover trial.

Chest·2026
Same journal

A Comparative Study of Radiation Exposure in Conventional and Robotic Bronchoscopy.

Chest·2026
Same journal

Independent Prognostic Contributions of Anti-Ro52 and Anti-MDA5 in Autoimmune-Associated Interstitial Lung Disease.

Chest·2026
Same journal

Lung aeration and gas exchange in SGA or AGA infants with moderate-severe BPD: secondary analysis of the PATH-BPD study.

Chest·2026
Same journal

Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

Chest·2026
Same journal

Symptom prevalence and impact on lung cancer risk in the SUMMIT study.

Chest·2026
See all related articles

Penicillin G is reconsidered for pneumococcal pneumonia due to rising resistance to other antibiotics. Optimized high-dose regimens and precise dosing guidelines are crucial for effective treatment, especially in severe cases.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Microbiology

Background:

  • Penicillin G was historically the primary treatment for pneumococcal pneumonia.
  • Challenges include diagnostic difficulties, increasing drug resistance, and unclear dosing guidelines.
  • Renewed interest in penicillin G is driven by resistance to newer antibiotics like cephalosporins and concerns about vancomycin overuse.

Purpose of the Study:

  • To review issues concerning penicillin G dosing for pneumococcal pneumonia.
  • To propose an optimized high-dose regimen for severe cases.
  • To provide guidance for dose adjustments in specific patient populations.

Main Methods:

  • Review of literature on penicillin G dosing strategies.
  • Analysis of intermittent versus continuous therapy.

Related Experiment Videos

  • Examination of dose-response relationships with pneumococcal resistance.
  • Consideration of cost-effective pharmacology.

    • Main Results:

    • An optimal high-dose regimen involves a loading dose followed by continuous infusion.
    • Specific dosing recommendations are provided for a 70-kg adult with life-threatening pneumonia.
    • A formula is proposed for adjusting maintenance doses in elderly patients and those with renal failure.
    • The proposed regimen achieves serum levels effective against most resistant strains.

    Conclusions:

    • Optimized high-dose penicillin G regimens can be effective for pneumococcal pneumonia.
    • Precise dosing is essential, particularly with emerging resistance.
    • Reserve newer antibiotics for specific indications like meningitis, endocarditis, or highly resistant infections.